SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-036964
Filing Date
2021-09-21
Accepted
2021-09-21 21:48:57
Documents
2
Period of Report
2021-09-21

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 4041
2 EX-24 DOCUMENT attachment1.htm EX-24 5075
  Complete submission text file 0000899243-21-036964.txt   10483
Mailing Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE E, SUITE 208 SEATTLE WA 98102 (858) 775-4523
Icosavax, Inc. (Issuer) CIK: 0001786255 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1616 EASTLAKE AVENUE E SUITE 208 SEATTLE WA 98102-3793
Business Address
Bekiroglu Elizabeth (Reporting) CIK: 0001884087 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40655 | Film No.: 211268020